NextCure Inc (NXTC)
1.70
+0.05
(+3.03%)
USD |
NASDAQ |
May 17, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
NextCure Cash from Investing (TTM): 39.03M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 39.03M |
| December 31, 2023 | 39.27M |
| September 30, 2023 | 39.58M |
| June 30, 2023 | 47.19M |
| March 31, 2023 | 72.40M |
| December 31, 2022 | 67.98M |
| September 30, 2022 | 52.51M |
| June 30, 2022 | 49.04M |
| March 31, 2022 | 32.70M |
| December 31, 2021 | 36.60M |
| September 30, 2021 | 64.10M |
| Date | Value |
|---|---|
| June 30, 2021 | 62.79M |
| March 31, 2021 | 55.75M |
| December 31, 2020 | 43.52M |
| September 30, 2020 | -100.14M |
| June 30, 2020 | -287.93M |
| March 31, 2020 | -297.62M |
| December 31, 2019 | -303.92M |
| September 30, 2019 | -178.67M |
| June 30, 2019 | -4.277M |
| March 31, 2019 | -3.533M |
| December 31, 2018 | -3.063M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-303.92M
Minimum
Dec 2019
72.40M
Maximum
Mar 2023
-23.50M
Average
39.42M
Median
Cash from Investing (TTM) Benchmarks
| Assertio Holdings Inc | 3.202M |
| DiaMedica Therapeutics Inc | -16.60M |
| Terns Pharmaceuticals Inc | -57.92M |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |